Levicept
Latest round
- Series A
Last raised
- Oct 2014
Total raised
- $16M
Investors
- 3
About Levicept
Levicept, founded in 2012, is based in Sandwich, UK, and specializes in the development of therapeutic solutions for chronic pain management. The firm has completed two deals to date, with LEVI-04 having successfully undertaken a phase II clinical trial, demonstrating its efficacy in treating chronic knee pain.Levicept is a biotechnology company dedicated to providing innovative solutions for chronic pain management, specifically targeting osteoarthritis. Their flagship product, LEVI-04, is a biological therapy that modulates the neurotrophin pathway through neurotrophin-3, aimed at delivering effective analgesia while minimizing side effects commonly associated with traditional pain medications such as opiates and NSAIDs. The product has successfully completed a phase II clinical trial demonstrating its efficacy in treating chronic knee pain, addressing a significant unmet need for over 1 billion individuals suffering from chronic pain globally. Levicept’s primary customers include healthcare providers and institutions that seek effective pain management options for their patients.Levicept’s revenue model is structured around partnerships with healthcare providers and institutions, as well as potential collaborations with pharmaceutical companies. The firm is expected to generate revenue through the distribution of LEVI-04, which will involve B2B transactions aimed at hospitals, clinics, and specialty pain management centers. Pricing structures may include tiered pricing based on volume purchases or agreements based on patient outcomes. The company aims to expand into key markets in Europe and North America by 2025, responding to the growing demand for effective pain management solutions. Furthermore, ongoing research and development efforts will focus on enhancing existing therapies and exploring new innovative approaches to pain management.
Who invested in Levicept
3 investors across 2 rounds
See all investors in Levicept
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Levicept
Who invested in Levicept?
Levicept has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Levicept raised?
Levicept has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Levicept last raise money?
Levicept's most recent round on record is a Series A, in Oct 2014.
What does Levicept do?
Levicept, founded in 2012, is based in Sandwich, UK, and specializes in the development of therapeutic solutions for chronic pain management.
Where is Levicept headquartered?
Levicept is headquartered in Sandwich, UK.
Which VCs invest in companies like Levicept?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Levicept's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Levicept? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.